Atlas Trials

An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease

Clinical trial NCT03362736 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03362736
Sponsor
Janssen Research & Development, LLC
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Crohn Disease

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.